While Fauci was lining the pockets of big pharma by peddling dangerous and experimental mRNA vaccines, Dr. Peter McCullough has been hard at work determining safe, scientific ways to combat spike protein effects.
As the nation’s preeminent cardiologist, and one of the most trusted medical voices during the pandemic, Dr. McCullough is dedicated to determining what are – and what are not – effective ways to overcome COVID19 and COVID19 vaccine injuries.
And now, this research is bearing fruits.
The ingredient that Fauci and big pharma don’t want you to know about is – Nattokinase.
Nattokinase is one of the key ingredients in The Wellness Company’s Spike Support formula (plus, ordering through this link and the links below benefits Gateway Pundit).
In recent articles, Dr. McCullough highlighted the safety of nattokinase in counteracting spike protein and potential cardiovascular damage:
“Approximately 15% of Americans who took a COVID-19 vaccine have some new medical illness and regret the shot. Many are looking to nattokinase in formulations of Spike protein support supplements.
Chen et al reviewed human studies before the pandemic on the use of nattokinase with this introduction: ‘Natto, a cheese-like food made of soybeans fermented with Bacillus subtilis, has been consumed as a traditional food in Asian countries for more than 2000 years. Natto consumption is believed to be a significant contributor to the longevity of the Japanese population. Recent studies demonstrated that a high natto intake was associated with decreased risk of total cardiovascular disease mortality and, in particular, a decreased risk of mortality from ischaemic heart diseases.
Before the 1980s, very little was known about the mechanism by which natto consumption led to overall cardiovascular health. In 1987, Sumi et al discovered that natto contained a potent fibrinolytic enzyme called nattokinase. Since then, a considerable amount of NK research has been performed on NK in Japan, Korea, China, and the United States, and these studies confirmed that NK, an alkaline protease of 275 amino acid residues with a molecular weight of approximately 28 kDa, is the most active ingredient of natto and is responsible for many favourable effects on cardiovascular health. First, nattokinase has potent fibrinolytic/antithrombotic activity. In addition, in both animal and human studies, NK also has an antihypertensive, anti-atherosclerotic, lipid-lowering, antiplatelet/anticoagulant, and neuroprotective actions…
The most unique feature of nattokinase is that, as a single compound, it possesses multiple cardiovascular disease preventative and alleviating pharmacologic effects (namely, antithrombotic, antihypertensive, anticoagulant, anti-atherosclerotic, and neuroprotective effects). There are no other drugs or drug candidates with multiple pharmacologic properties similar to nattokinase. In addition, nattokinase is a natural product that can be administered orally, has a proven safety profile, is economical to use, and provides distinct advantages over other pharmaceutical products.’
In summary this review is reassuring that the ever-increasing use of nattokinase in post-COVID-19 and after COVID-19 vaccine injuries is safe and reasonably well tolerated. There may be additional benefits on the cardiovascular system.”